A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

Clinical trial NCT04527328 · COMPLETED

Trial details

NCT number: NCT04527328
Sponsor: Alkahest, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cognitive Impairment End Stage Renal Disease

Start date: 2020-04-28
Primary completion: 2021-06-04
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.